Truist cuts Brown & Brown stock price target to $85 on lower estimates
Truist Securities reduced its price target for Brown & Brown (NYSE:BRO) to $85 from $90, citing lower 2026 and 2027 EPS estimates. The firm maintained a Buy rating, basing the target on a 14x multiple of its 2027 EBITDA estimate. BRO's Q3 earnings missed expectations, with revenue at $1.72B and EPS at $1.07, though both showed year-over-year growth. The company's organic growth slowed, and its adjusted EBITDAC margin declined by 200 basis points.
How this was made
The 30-second read
Why it matters
The analyst downgrade and earnings miss are likely to push the stock lower in the short term.
Market read
BRO's price target reduction and earnings shortfall provide a fresh catalyst for traders, suggesting downside risk.
What to watch
Accession acquisition synergies and long‑term margin recovery could offset short‑term miss.
Background
Brown & Brown is a U.S. insurance brokerage that recently reported Q3 results and received a revised analyst outlook.
Ticker impact
Truist lowered its price target on Brown & Brown to $85 and cut 2026‑2027 EPS forecasts after the company reported Q3 earnings that missed estimates.
likely pressure as the market prices in the lower guidance and target.
Analyst target cut and earnings shortfall are fresh, material information that typically drives the stock lower.
Market effects
May weigh on other insurance brokerage stocks as guidance tightening spreads.
Limited to U.S. insurance sector.
Low global impact.
Counterpoint
If the market overreacts, the stock could rebound on the 7% YoY profit growth.
Key entities
- CompanyBrown & Brown
Insurance brokerage firm (NYSE:BRO).
- AnalystTruist Securities
Research firm that issued the price‑target cut.
